Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation EuroPCR 2024

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

Presenter: Hans-Josef Feistritzer

May 14, 2024

Presentation EuroPCR 2023

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

Presenter: Shigeru Saito

May 18, 2023

Presentation EuroPCR 2019

The Mitral Valve Repair Clinical (MAVERIC) trial

Presenter: Simon Redwood

May 21, 2019

Presentation EuroPCR 2019

Five-year outcomes after TAVI with balloon-expandable vs. self-expanding valves: Results from the CHOICE randomised clinical trial

Presenter: Mohamed Abdel-Wahab

May 21, 2019

Presentation EuroPCR 2019

Relationship Between Residual Mitral Regurgitation and Clinical and Functional Outcomes in the COAPT Trial

Presenter: Saibal Kar

May 21, 2019

Presentation EuroPCR 2018

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Presenter: Simon Redwood

May 24, 2018

Presentation EuroPCR 2018

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

Presenter: David E. Kandzari

May 23, 2018

Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve The ARTE Randomized Clinical Trial

Presentation EuroPCR 2017

The ARTE Randomized Clinical Trial

Presenter: Josep Rodés-Cabau

May 17, 2017

Presentation EuroPCR 2015

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Presenter: Sigmund Silber

May 19, 2015

Presentation EuroPCR 2013

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Presenter: 203171|Ian Meredith

May 31, 2013

Presentation EuroPCR 2013

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

Presenter: 228635|John Ormiston

May 31, 2013

Presentation EuroPCR 2013

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

Presenter: Alexandre Abizaid

May 21, 2013

Advertisement

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

The Mitral Valve Repair Clinical (MAVERIC) trial

Five-year outcomes after TAVI with balloon-expandable vs. self-expanding valves: Results from the CHOICE randomised clinical trial

Relationship Between Residual Mitral Regurgitation and Clinical and Functional Outcomes in the COAPT Trial

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

The ARTE Randomized Clinical Trial

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content